Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
06/2003
06/18/2003EP1075475B1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
06/18/2003EP0819125B1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
06/18/2003CN1425016A Benzoxathiepino [3,4-b] pyridine derivatives, process for their preparation and their use as medicaments
06/18/2003CN1424915A Oral, nasal and pulmonary dosage formulations of copolymer1
06/18/2003CN1424910A IL-8 receptor antagonists
06/18/2003CN1424108A Defatted rana amurensis ovary powder for women healthy food
06/18/2003CN1424101A Chinese medicines for treating dymenorrhea
06/18/2003CN1424069A Medicines for treating sterility
06/18/2003CN1424064A Healthy medicinal spirit for tonifying kidney and strengthening Yang
06/18/2003CN1424061A Spirit for restoring menstrual flow
06/18/2003CN1424060A Galactogogue
06/18/2003CN1424049A Oral medicine for mastadenitis and mammary pains and preparing method thereof
06/18/2003CN1424044A Gene medicine against mammitis of dairy cow
06/18/2003CN1423976A Food therapy by Wanshou fruit milk
06/18/2003CN1111529C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111528C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111427C Extract of cimicifuga rhizome and its preparation process and application
06/18/2003CN1111414C Use of magnesium salts or magnesium complex as production of medicines
06/18/2003CN1111404C Controlled release oxybutynin formulation
06/17/2003US6579968 Cyclic peptide of given amino acid sequence; stimulates male erection; less side effects; melanocortin receptor-specific pharmaceutical composition
06/17/2003US6579893 Related thiazolidinediones
06/17/2003US6579892 Affective disorders; neurotic, stress and somatoform disorders and psychoses, e.g. schizophrenia 3-(3-(6-Methyl-1,2,3,4-tetrahydronaphth-2-ylamino)propylmercap to) -4-methyl-5-phenyl-1,2,4(4H)-triazole
06/17/2003US6579870 5-(1,4-diazepan-1-yl)-2-((3 -fluorophenyl)sulfonyl)phenylamine for example; treatment of diseases or disorders of the central nervous system; modulation of serotonin (5-HT) activity
06/13/2003WO2003047602A1 Immunostimulatory oligodeoxynucleotides
06/13/2003CA2452909A1 Immunostimulatory oligodeoxynucleotides
06/12/2003WO2003048183A2 Method for obtaining oestrogen from mare urine
06/12/2003WO2003048180A1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
06/12/2003WO2003048160A1 Ring fused pyrazole derivatives
06/12/2003WO2003048141A1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
06/12/2003WO2003048117A2 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
06/12/2003WO2003048116A2 Esters and amides as ppar-alpha agonists ____________
06/12/2003WO2003047597A1 Combination of crystalline form of a ribofuranosyluronamide derivative and tiotropium salt
06/12/2003WO2003047588A1 Kit for reducing aching caused by pde-v inhibitors
06/12/2003WO2003047563A1 Use of alkanoyl l-carnitine for the treatment of erectile dysfunction
06/12/2003WO2003047555A1 Transdermal therapeutic systems containing steroid hormones and propylene glycol monocaprylate
06/12/2003WO2003047554A1 Transdermal drug delivery system of strychnine, brucine, securinine and their salts
06/12/2003WO2003047504A2 Prevention and treatment of androgen-deprivation induced osteoporosis
06/12/2003WO2003047367A1 Solid and stable creatine/citric acid composition(s) and compositions containing carbohydrate(s) or hydrates thereof, method for the production and use thereof
06/12/2003WO2003005962A3 Methods for treatment of cognitive and menopausal disorders with d-threo methylphenidate
06/12/2003WO2002000192A8 Embolization using carbon coated particles
06/12/2003WO2001071007A3 GENETIC POLYMORPHISM OF MxA PROTEIN AND USE THEREOF
06/12/2003US20030109562 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1, 6,9-trioxa-3-aza-cyclopenta[a]naphthalene
06/12/2003US20030109556 Melanocortin receptor ligands
06/12/2003US20030109545 Their solvates and/or hydrates exhibiting an affinity and a selectivity for arginine-vasopressin V1b receptors or for both V1b and V1a receptors.
06/12/2003US20030109535 GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure:prodrugs, stereoisomers and drugs
06/12/2003US20030109532 Modulators of dopamine neurotransmission
06/12/2003US20030109524 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
06/12/2003US20030109452 Containing phenylalanine, leucine, alanine, and lysine residues are disclosed. The peptides can be used in antibacterial, antifungal, anticancer, and other biological applications.
06/12/2003US20030109437 Peptides and methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using proteins (and peptides derived from the amino acid sequences of such
06/12/2003US20030109429 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
06/12/2003US20030109018 Novel endometriosis-associated gene
06/12/2003US20030108965 Using polypeptide, detection of antibody; cancer of ovaries
06/12/2003US20030108928 MID 241 receptor, a novel G-protein coupled receptor
06/12/2003US20030108621 Use of iodide salt as an aphrodisiac
06/12/2003US20030108544 Compositions and methods for the diagnosis and treatment of tumor
06/12/2003US20030108540 Inducing apoptosis in tissues; binding antibodies
06/12/2003US20030108509 Containing sodium dodecyl sulfate
06/12/2003US20030108496 Compositions comprising phenyl-glycine derivatives
06/12/2003CA2537913A1 Prevention and treatment of androgen-deprivation induced osteoporosis
06/12/2003CA2469227A1 New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
06/12/2003CA2468927A1 Ring fused pyrazole derivatives
06/12/2003CA2465395A1 Transdermal therapeutic systems containing steroid hormones and containing propylene glycol monocaprylate
06/11/2003EP1317924A1 Kit for reducing aching caused by pde-v inhibitors
06/11/2003EP1317537A2 G-csf analog compositions and methods
06/11/2003EP1317531A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof
06/11/2003EP1317478A2 DISCRIMINATION BETWEEN GnRH-I AND GnRH-II
06/11/2003EP1317465A1 Purine derivatives
06/11/2003EP1317458A2 Interphenylene 7-oxabicyclic[2.2.1]heptane oxazoles as prostaglandin f2alpha antagonists
06/11/2003EP1317457A2 INTERHETEROARYL 7-OXABICYCLIC 2.2.1]HEPTANE OXAZOLES AS PROSTAGLANDIN F 2$g(a)? ANTAGONISTS
06/11/2003EP1317456A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
06/11/2003EP1317453A1 Isoxazoles and their use as inhibitors of erk
06/11/2003EP1317433A2 Inhibitors of glycogen synthase kinase 3
06/11/2003EP1317428A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors
06/11/2003EP1317420A1 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317417A2 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317413A1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
06/11/2003EP1317309A2 Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant
06/11/2003EP1317286A2 Contraception process and administration form for the same
06/11/2003EP1317283A2 Tweak receptor agonists as anti-angiogenic agents
06/11/2003EP1248637A4 Pharmaceutical composition comprising pectin effective in inhibiting the male reproductive toxicity
06/11/2003EP0938325B1 Methods for sterilizing male mammals
06/11/2003CN1423692A Human Muellerian Duct-derived epithelial cells and methods of isolation and uses thereof
06/11/2003CN1423646A Hetero cyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
06/11/2003CN1423565A 精子因子oscillogenin Sperm factor oscillogenin
06/11/2003CN1423560A Male contraceptive formulation comprising norethisterone
06/11/2003CN1423557A Intracorporeal medicaments for photodynamic treatment of disease
06/11/2003CN1422849A 吲唑衍生物 Indazole derivative
06/11/2003CN1422658A Medicine for treating menalgia
06/11/2003CN1422652A Chinese medicinal preparation for treating gynaecology disease of cervicitis
06/11/2003CN1422651A Medicine for treating gynaecology and obstetrics disease and preparation method
06/11/2003CN1422636A Chinese medicine preparation for treating climacteric metancholia of women
06/11/2003CN1111065C Plaster for curing mastosis
06/11/2003CN1111063C Capsule for treating gonorrhoea and its preparation process
06/11/2003CN1111056C Liquid medicine ÔÇÿFujieyeÔÇÖ"
06/11/2003CN1111046C Chinese medicine preparation for curing postpartum disease of woman
06/10/2003US6576793 β2-adrenergic receptor agonists
06/10/2003US6576666 First fatty acid compound that is a linoleic or linolenic compound and a second fatty acid that is a docosahexaenoic acid compound, an omega-3 or an omega-2 fatty acid or derivative
06/10/2003US6576648 Compound with growth hormone releasing properties
06/10/2003US6576645 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
06/10/2003US6576644 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
1 ... 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 ... 557